Company overview
Spear Bio offers SPEAR UltraDetect, a homogeneous immunoassay platform for ultrasensitive protein biomarker detection using patented two-factor authentication and qPCR amplification. It enables attomolar sensitivity from 1 µL samples, targeting neurology biomarkers like pTau231, pTau217, GFAP, and NfL for neurodegenerative disease research. The technology supports research-use-only applications with services for custom assay development and biomarker analysis.
Spear Bio is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include ultrasensitive immunoassay, protein biomarker detection, spear technology, neurology biomarkers, ptau231 assay.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Spear Bio include Assay — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://spear.bio
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- ultrasensitive immunoassay, protein biomarker detection, spear technology, neurology biomarkers, ptau231 assay
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biomarkers does Spear Bio's SPEAR UltraDetect target?
- Initial assays target neurology biomarkers: phosphorylated tau 231 (pTau231), phosphorylated tau 217 (pTau217), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL).
- What is the sensitivity and sample requirement for SPEAR assays?
- SPEAR UltraDetect achieves attomolar biomarker measurement with 1 µL of diluted sample, offering high specificity via two-factor authentication and low CV (<5%) in a wash-free workflow.
- What services does Spear Bio provide for custom needs?
- Services include platform evaluation, custom assay development, and biomarker analysis to support academic research and publications.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
